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Abstract
Background. Integration of depression treatment into primary care could improve patient
outcomes in low-resource settings. Losses along the depression care cascade limit integrated
service effectiveness. This study identified patient-level factors that predicted detection of
depressive symptoms by nurses, referral for depression treatment, and uptake of counseling,
as part of integrated care in KwaZulu-Natal, South Africa.
Methods. This was an analysis of baseline data from a prospective cohort. Participants were
adult patients with at least moderate depressive symptoms at primary care facilities in
Amajuba, KwaZulu-Natal, South Africa. Participants were screened for depressive symptoms
prior to routine assessment by a nurse. Generalized linear mixed-effects models were used to
estimate associations between patient characteristics and service delivery outcomes.
Results. Data from 412 participants were analyzed. Nurses successfully detected depressive
symptoms in 208 [50.5%, 95% confidence interval (CI) 38.9–62.0] participants; of these,
they referred 76 (36.5%, 95% CI 20.3–56.5) for depression treatment; of these, 18 (23.7%,
95% CI 10.7–44.6) attended at least one session of depression counseling. Depressive symp-
tom severity, alcohol use severity, and perceived stress were associated with detection.
Similar factors did not drive referral or counseling uptake.
Conclusions. Nurses detected patients with depressive symptoms at rates comparable to
primary care providers in high-resource settings, though gaps in referral and uptake persist.
Nurses were more likely to detect symptoms among patients in more severe mental distress.
Implementation strategies for integrated mental health care in low-resource settings should
target improved rates of detection, referral, and uptake.
Introduction
An estimated 75% of South Africans experiencing mental disorder never receive any kind of
mental health treatment (Seedat et al., 2009). Common mental disorders (CMDs) like depres-
sion, anxiety, and alcohol abuse frequently coexist with the growing syndemics of HIV and
other chronic diseases (Myer et al., 2008; Pappin et al., 2012; Bhana et al., 2015) and limit
the effectiveness of therapies for these physical diseases by reducing medication adherence
and retention in care (Peltzer et al., 2010; Nakimuli-Mpungu et al., 2012). South Africans
who do seek mental health services are over three times more likely to do so from a general
medical provider than from a mental health specialist (Seedat et al., 2009). Integration of
evidence-based mental health care into routine chronic disease services at the primary health
care (PHC) level has been advanced by the South African National Mental Health Policy
Framework and Action Plan (2013–2020) as an important strategy to reduce the treatment
gap and improve associated mental and physical health outcomes (Collins et al., 2011;
National Department of Health, 2014).
Evidence from high-income countries suggests that collaborative models for the integration
of mental health care into the PHC platform can be cost-effective for patients with co-morbid
chronic illness (Woltmann et al., 2012). Integrated care models have also demonstrated
promising effectiveness in South Africa (Petersen et al., 2019). PHC-based professional nurses
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– clinical nurse practitioners (CNPs) – are at the core of the South
African model for integrated care: they are responsible for detect-
ing patients with co-morbid CMDs during routine care for chronic
diseases like HIV and hypertension, providing brief psycho-edu-
cation, referring patients into appropriate mental health treat-
ment, and managing their ongoing care (Fairall et al., 2018;
Petersen et al., 2018). Implementation strategies for this model
include training CNPs in the use of a national standard clinical
decision support tool, outreach and change management work-
shops with clinic staff, and the addition of in-facility counseling
by trained lay counselors. However, early evidence from this
model suggested that, once trained, CNPs were able to positively
detect only 16–27% of patients with depression (Petersen et al.,
2019). Such losses along the depression care cascade threaten
the overall effectiveness of integrated care in this context. Both
CNPs and patients face unique, multi-level barriers to delivery
and receipt of services for depression and other CMDs
(Anthony et al., 2010); identification of these barriers will enable
targeted refinements to the integrated care model and its imple-
mentation strategy (Jacobs et al., 2015).
Patient-level predictors of detection, referral, and treatment
uptake are particularly relevant given that integrated care models
require providers to holistically meet the diverse needs of patients
with multiple co-morbidities (Watt et al., 2017). It is therefore
important to understand whether variation in patient sociodemo-
graphic characteristics, clinical presentation, and medical history
predicts whether patients successfully receive treatment. Our
objective was to identify patient-level factors that predicted suc-
cessful detection of depressive symptoms by CNPs, referral for
depression-related treatment, and uptake of depression counsel-
ing, as part of integrated primary mental health care in
KwaZulu-Natal, South Africa.
Methods
Conceptual model
Our approach was informed by the idea of the depression treat-
ment cascade; that is, among patients in primary care with
co-morbid chronic disease and depression, a proportion will be
detected as having probable depression by providers; a proportion
of those will be referred into appropriate depression treatment; a
proportion of those will take up treatment; and a proportion of
those will experience remission (Pence et al., 2012). Patient losses
are thus anticipated at each level of the cascade. By targeting steps
with large losses – and modifiable factors that predicted those
losses – overall rates of depression remission can be improved.
This study investigates the first three steps: detection, referral, and
treatment uptake.
Integrated care model
An integrated, collaborative approach to the management of
depression and other CMDs was developed and evaluated in
South Africa with the support of the Programme for Improving
Mental Healthcare (PRIME) consortium [40]. The history and
design of this model have been described in detail elsewhere
(Fairall et al., 2018; Petersen et al., 2018). It was piloted and trialed
in North West Province, and scaled to Amajuba District in
KwaZulu-Natal with the support of the President’s Emergency
Plan For AIDS Relief (PEPFAR). The model was built from
South Africa’s efforts to deliver the majority of care for chronic
disease at a single PHC-level service point. It involved strengthen-
ing the capacity of CNPs to identify and manage patients with
depression and other CMDs, and of sessional PHC physicians to
treat CMDs; training PHC-based lay behavioral health counselors
to provide up to eight sessions of individual- or group-based
evidence-based counseling; and reinforcing necessary referral path-
ways, monitoring systems, and supervisory structures. In Amajuba,
lay HIV counselors at each facility were trained as behavioral health
counselors. Implementation of the model in Amajuba was sup-
ported by a cross-cutting, health systems strengthening approach.
Continuous quality improvement methods were used to overcome
early bottlenecks and strengthen the system’s capacity to provide
mental health services alongside services for other chronic diseases.
CNPs received supplemental training in clinical communica-
tion skills and in the mental health components of a national
standard clinical decision support tool (Adult Primary Care, or
APC) (Fairall et al., 2015). Training was provided through a
train-the-trainer approach: nurse master trainers at each PHC
were trained to deliver four sessions of supplemental material to
their peers. The APC tool includes algorithms and checklists
developed to support nurse-led identification and management
of all common chronic diseases, including depression and other
CMDs. CNPs use the steps outlined in the APC tool to screen
chronic care patients for depression and other CMDs, make an
assessment based on clinical presentation and patient medical his-
tory, provide brief psycho-education, write appropriate referrals,
and manage ongoing care. They may refer directly to the APC
flowcharts during patient consultations, or they may review the
flowcharts before and after patient consultations. Based on their
assessment, CNPs can refer patients to the PHC-based behavioral
counselor. Depending on case severity, they can also refer patients
for diagnostic confirmation and/or treatment by a sessional phys-
ician or district hospital-based psychologist.
Data source
We analyzed baseline data from the prospective cohort of the
implementation study of the scale-up of the integrated care
model described above (Petersen et al., 2019). This cohort was
part of the Southern African Research Consortium for Mental
health INTegration (S-MhINT). From April to October 2018,
patients attending chronic disease services at 10 different PHC
facilities in Amajuba District, KwaZulu-Natal, South Africa,
were invited to participate in the cohort study. These facilities
had been implementing the integrated collaborative mental health
model since late 2017. Amajuba District’s public health system
covers a mostly peri-urban population, was one of KwaZulu-
Natal’s three provincial pilot sites for South Africa’s National
Health Insurance program, and was noted as high-performing
by the country’s Ideal Clinic Monitoring System (Department
of Health, 2019).
Trained fieldworkers administered a brief screening tool,
including assessments of depressive symptoms (PHQ-9) and alco-
hol use (AUDIT), to interested patients. Both have been validated
for use in South African populations (Myer et al., 2008; Bhana
et al., 2015). Patients were eligible for enrollment in the cohort
if they were at least 18 years old; had the time and ability to com-
plete the baseline interview; and scored ⩾9 on the PHQ-9 and/or
⩾8 on the AUDIT. Patients were excluded from enrollment if they
were unable to provide informed consent (e.g. in case of severe
intellectual disability, acute medical issue, or lack of private
space) or were planning to leave the study area within 12 months.
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Most cohort participants – and all participants included in this
analysis – were recruited from the chronic care waiting room,
prior to routine assessment and consultation with the CNP. In
an effort to increase the cohort sample size of patients who had
received a referral for depression treatment, the fieldworkers sub-
sequently recruited some participants post-referral. Facility-based
behavioral counselors notified fieldworkers when they received
new patient referrals to that fieldworkers could approach the
referred patients directly, prior to their scheduled first counseling
session. Participants were only eligible for this current analysis if
they were enrolled prior to routine assessment by the CNP (i.e.
their enrollment was not conditional on detection or referral),
and if they scored ⩾9 on the PHQ-9. Participants recruited post-
referral were excluded.
During screening, if patients responded positively to the suicidal
ideation question of the PHQ-9, fieldworkers repeated the question
to confirm the response. Patients reporting suicidal thoughts in the
past two weeks were given psychoeducational material and contact
details for accessing help, and those reporting suicidal thoughts on
more than seven days in the past two weeks were referred directly
to the CNP for assessment and onward referral to the sessional
physician or psychologist if necessary.
Following written informed consent, participants completed a
baseline questionnaire in their choice of English or isiZulu.
Questionnaire data were collected using tablets. With the excep-
tion of suicidal ideation, as noted above, screening results, cohort
enrollment, and questionnaire data were not reported to CNPs;
CNPs assessed and cared for patients as usual, blinded to the
screening results. Fieldworkers then tracked the mental health-
related service delivery outcomes of enrolled patients, including
CNP detection of depressive symptoms and referral for
depression-related treatment, using CNP-completed checklists
and patient records. All study procedures were approved by the
Biomedical Research Ethics Committee of the University of
KwaZulu-Natal (BF190/17) and by the Department of Health of
the Province of KwaZulu-Natal.
Outcomes
We assessed three outcomes of interest. The first was detection of
depressive symptoms by the nurse, defined as the PHC-based
CNP noting the depressive symptoms in the patient record or
indicating on the checklist that the patient had a probable case
of depression. The second was referral for depression-related
treatment, defined as the CNP completing a referral form for
counseling by the PHC-based behavioral counselor. Referrals
may also be made for diagnostic confirmation and/or treatment
by a PHC-based physician or district hospital-based psychologist.
The second outcome was conditional on the first, as a referral
could not be made without first detecting the depressive symp-
toms. The third was uptake of depression-related counseling
from a PHC-based behavioral counselor. For the purpose of
this analysis, uptake was defined as attendance of at least one ses-
sion; this served to maximize sample size across the outcome
strata, given low uptake of subsequent sessions. The third out-
come was conditional on the first and second outcomes, as coun-
seling uptake could not occur without both detection and referral.
Predictors
We examined predictors related to patient socio-demographic
characteristics, healthcare use, prior chronic disease diagnoses,
assessment of the quality of chronic illness care, perceived stress,
social support, general disability, and clinical characteristics.
Socio-demographic characteristics were age, sex, race, educational
attainment, employment status, employment and social grant-
related income, and self-reported household food insecurity.
Healthcare use was measured by self-report of the number of
PHC visits and number of hospitalizations in the previous 3
months. Prior diagnoses were measured by self-report and
included depression, HIV, asthma, chronic obstructive pulmonary
disease, hypertension, heart disease, stroke, tuberculosis, diabetes,
high cholesterol, arthritis, epilepsy, and other chronic and mental
disorders. Assessment of prior chronic illness care was measured
using the Patient Assessment of Chronic Illness Care (PACIC),
which evaluates the quality of care and alignment with the
chronic care model (Glasgow et al., 2005). Perceived stress was
measured using the perceived stress scale (PSS), which assesses
the extent to which situations in a person’s life are appraised as
stressful (Cohen et al., 1983). Social support was measured using
the Oslo social support scale (Dalgard et al., 2006); this three-item
instrument asks about numbers of close confidants, sense of con-
cern from other people, and relationships with neighbors, with a
focus on the availability of practical help. General disability was
measured with the 12-item interviewer-administered version of
the WHO Disability Assessment Schedule (WHODAS), which
is a generic assessment instrument for disability for diseases
including mental disorders (Garin et al., 2010). Clinical character-
istics included depressive symptom and alcohol use severity.
Depressive symptoms were measured with the PHQ-9, which is
aligned with the Diagnostic and Statistical Manual (DSM-IV-TR)
diagnostic criteria for major depressive disorder (Kroenke et al.,
2010). Scores between 9 and 14 indicated moderate depression,
between 15 and 19 indicated moderately severe depression, and
between 20 and 27 indicated severe depression. Alcohol use was
measured with the AUDIT (Saunders et al., 1993). All measures
have been previously used and found to be valid in South Africa
( Myer et al., 2008; Garin et al., 2010; Vythilingum et al., 2012;
Bhana et al., 2015).
Statistical analysis
Descriptive analyses, including univariate logistic regression models
adjusting for clustering at the health facility level, were conducted
to summarize and compare participant characteristics stratified
by service delivery outcome: not detected v. detected, not referred
v. referred, and no treatment uptake v. any treatment uptake. We
then used generalized linear mixed-effects models to estimate asso-
ciations between the predictors of interest and the nested service
delivery outcomes. All three models used the binomial family
and logit link and included random facility-specific intercepts to
adjust for clustering. As a sensitivity test for type II error, we
included parsimonious models with only covariates with adjusted
p values < 0.1. Finally, we used the model estimates to calculate
and plot the predicted probabilities of detection, referral, and
uptake over the range of PHQ-9 scores observed at screening,
with all other covariates at their means (King et al., 2000).
All analyses were performed in Stata and R (R Core Team, 2017;
StataCorp, 2015). Statistical significance was defined at α = 0.05.
Results
We screened 1404 patients for study eligibility; 662 patients were
eligible for enrollment and recruited into the cohort (Fig. 1). Five
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hundred and fifty-eight participants had PHQ-9 scores ⩾ 9, of
whom 412 were enrolled prior to CNP assessment and were eli-
gible for this analysis. Overall, CNPs detected depressive symp-
toms in 208 [50.5%, cluster-adjusted 95% confidence interval
(CI) 38.9–62.0] participants; of these, they referred 76 (36.5%,
95% CI 20.3–56.5) for depression treatment; of these, 18
(23.7%, 95% CI 10.7–44.6) received at least one session of depres-
sion counseling. Overall, 18.4% (95% CI 9.0–34.2) of participants
were referred for depression treatment, and 4.4% (95% CI 1.6–
11.5) of participants received at least one session of depression
counseling. On average, participants receiving any treatment
attended 1.7 sessions (range 1–8); one participant completed all
eight sessions. Participants with moderately severe (62.1%, 95%
CI 47.6–74.7) or severe depressive symptoms (76.9%, 95% CI
43.2–93.6) were more likely to be detected compared to partici-
pants with moderate depressive symptoms (42.8%, 95% CI
30.0–56.6) (Fig. 2, p = 0.013). Among detected participants, parti-
cipants with moderate (37.0%, 95% CI 16.8–63.0), moderately
severe (35.6%, 95% CI 15.8–61.9), and severe depressive symp-
toms (36.7%, 95% CI 14.6–66.2) were similarly likely to be
referred for treatment ( p = 0.99). Among referred participants,
participants with moderate (27.3%, 95% CI 9.5–57.3), moderately
severe (23.8%, 95% CI 10.2–46.2), and severe depressive symp-
toms (9.1%, 95% CI 0.5–67.0) were similarly likely to uptake treat-
ment ( p = 0.52).
The mean participant age was 44.3 years [standard deviation
(S.D.) 13.2] (Table 1). The majority were female (337, 81.8%),
almost all were Black (410, 99.5%), and few (88, 21.4%) had
matriculated from high school. Overall, the majority (278,
67.5%) had moderate depressive symptoms, and most (332,
80.6%) had low-risk alcohol use. Participants taking up treatment
were more likely to have low household income [⩽2000 South
African Rand (ZAR) per month] compared to participants not
taking up treatment (83.3% v. 70.7%, p = 0.020), and more likely
to report household food insecurity (66.7% v. 46.6%, p = 0.036).
Few (21, 5.1%) participants had been hospitalized in the previous
3 months. The majority had an HIV diagnosis prior to study
enrollment (318, 77.6%); detected participants were slightly
more likely to have an HIV diagnosis (80.3% v. 74.8%, p =
0.040) and to have reported a prior diagnosis of depression com-
pared to undetected participants (8.2% v. 3.0%, p = 0.020). Both
diagnosed and referred participants were less likely than
un-detected and un-referred participants to have reported a
prior diagnosis for a chronic disease other than HIV, hyperten-
sion, or diabetes (37.2% v. 28.1%, p = 0.019; 26.7% v. 43.2%,
p = 0.005, respectively). Over one-third (161, 39.2%) of all partici-
pants reported prior diagnoses of two or more chronic diseases.
Almost none were currently taking anti-depressant medication
(3, 0.7%). Participants perceived the quality of their chronic
care to be low overall (mean PACIC 0.44, S.D. 0.48). Detected par-
ticipants were more likely than undetected participants to have
reported high stress (30.0% v. 15.8%, p = 0.005) and to have
reported higher disability (WHODAS score of 0.28 v. 0.22, p =
0.014). They were also more likely to have severe depressive symp-
toms (14.4% v. 4.4%, p = 0.013), to report any suicidal thoughts
(48.1% v. 28.4%, p = 0.03), and to have high-risk and dependent
alcohol use (11.5% v. 2.5%, p = 0.002). Participants receiving a
referral for depression treatment were less likely than those
detected but not referred to report high social support (9.3% v.
16.8%, p < 0.001).
Regression models found that depressive symptom severity,
suicidal thoughts, and perceived stress were all independently
associated with detection by the CNP (Table 2). Specifically,
each additional point in PHQ-9 score was associated with a
12% increase in odds of detection [adjusted odds ratio (aOR)
1.12, 95% CI 1.04–1.20], reporting any suicidal thoughts was asso-
ciated with a 78% increase in odds of detection (aOR 1.78, 95% CI
1.02–3.11), and each additional point in PSS score was associated
with an 11% increase in odds of detection (aOR 1.11, 95% CI
1.06–1.17). No other predictors were independently, statistically
significantly associated with detection. In contrast, prior diagnosis
of a chronic disease other than HIV or depression was the only
predictor significantly associated with referral for depression
treatment, conditional on detection: prior diagnosis of another
chronic disease was associated with 57% reduced odds of referral
(aOR 0.43, 95% CI 0.18–0.99). No other predictors were inde-
pendently, statistically significantly associated with referral.
Finally, social support was the only predictor significantly asso-
ciated with uptake of depression counseling, conditional on refer-
ral: each point of additional Oslo score was associated with a 39%
reduction in odds of any treatment uptake (aOR 0.61, 95% CI
0.40–0.92). Sensitivity analyses using parsimonious models sup-
ported these findings (online Supplemental Table S1).
The predicted probability of depressive symptom detection
rose from 29.8% (95% CI 18.9–43.4) at the lowest level of
observed depressive symptoms to 93.8% (95% CI 83.0–97.8) at
the highest level, holding all other covariates at their means
(Fig. 3). In contrast, the predicted probability of treatment referral
rose from 24.4% (95% CI 10.9–46.1) at the lowest level of
observed depressive symptoms to 42.2% (95% CI 14.4–75.9) at
the highest level, holding all other covariates at their means.
Finally, the predicted probability of counseling uptake fell from
31.4% (95% CI 6.4–78.2) at the lowest level of observed depressive
symptoms to 3.8% (95% CI 0.1–54.2) at the highest level, holding
all other covariates at their means.
Discussion
This study is among the first to characterize disparities in depres-
sion detection, referral, and counseling uptake, across patient
sociodemographic and clinical characteristics, in an low- or mid-
dle-income country setting. Patients in the sample were mostly
Black, low-income women living with HIV and experiencing
moderate depressive symptoms. Many had two or more chronic
disease diagnoses, though few had a prior diagnosis of depression.
CNPs successfully detected depressive symptoms in nearly half of
the sample; among those they detected, they referred just over
one-third into treatment; among those with a referral, only one-
quarter received any depression counseling. CNPs were more
likely to detect depressive symptoms in patients with greater
Fig. 1. Cohort recruitment flow diagram.
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depressive symptom severity, alcohol use severity, and perceived
stress, independent of other patient-level clinical and socio-
demographic characteristics. These same factors did not drive
referral into treatment or counseling uptake, though lower-
income patients and those with lower social support were some-
what more likely to receive referrals and uptake treatment.
These results reflect a substantially higher rate of successful
nurse detection compared to the rate found by the PRIME evalu-
ation of this model in North West province (Petersen et al., 2019);
indeed, this rate of detection closely matches global findings sug-
gesting that, on average, PHC-based providers correctly detect
depressive symptoms about half of the time (Mitchell et al.,
2009). The rate of referral seen in this study also closely matches
rates of treatment initiation proximal to mood disorder onset
seen in other high- and middle-income settings (Wang et al.,
2005; Wang et al., 2007; Thornicroft et al., 2017). The clinical inter-
ventions and provider-level implementation strategies used to sup-
port the integrated care model were the same in this study and in
the PRIME evaluation. Contextual differences between the two dis-
tricts may explain the comparably high detection rate observed by
this study: as noted above, the health system of Amajuba district is
considered high-performing (Department of Health, 2019).
Moreover, the use of systems-level continuous quality improvement
methods to promote buy-in among program and operational man-
agers was novel in Amajuba. Both differences suggest that detection
rates are higher given a supportive, well-functioning health system
and appropriate levels of organizational support.
Still, many patients were missed. Although studies in the USA
have identified significant disparities across the depression treat-
ment cascade by sex and race (Simpson et al., 2007; Bengtson
et al., 2016), we found no evidence that sociodemographic char-
acteristics were associated with the likelihood of detection or
referral in this context. Instead, nurses in our study appeared to
be more influenced by clinical characteristics rather than sociode-
mographic characteristics. For example, we found that alcohol use
symptoms were positively associated with detection of depressive
symptoms, in contrast with findings from other settings (DiPrete
et al., 2019). Interestingly, perceived stress and depressive symptom
severity were both independently associated with detection of
depressive symptoms, suggesting that PHC-based CNPs may inter-
pret signs of stress as indicators of depression. However, mental
distress was not a key determinant of referral or uptake, and overall
probabilities of referral and uptake were low even among patients
with severe depressive symptoms and suicidal ideation. We
hypothesize that contextual determinants of implementation suc-
cess at the nurse-, facility-, system-, and community-levels may
be inhibiting these outcomes. For example, rates of successful
referral and treatment uptake likely relate to the competence of
CNPs in the assessment of patient mental health, the time available
to CNPs to complete referral forms, the competence of facility-
based behavioral counselors, and their availability and accessibility
to referred patients when needed. This suggests that there may be
opportunities to strengthen or enhance the implementation of the
integrated care model in this setting, and that future research will
need to assess higher-level predictors of referral and uptake.
This study had several limitations. First, in the absence of diag-
nostic assessment by psychiatrists or equivalent professionals, we
relied on screening by fieldworkers using the PHQ-9 as an indi-
cator of depressive symptoms and probable depression. This
approach may have led to misclassification of some patients; we
cannot report the true number of patients meeting criteria for a
depressive disorder, nor can we report the true number of patients
needing specialty mental health treatment. However, given that
the process of nurse-led identification of depressive symptoms
described in the APC manual is intended to be comparable to
screening, and not to professional diagnostic assessment, the
comparisons made in this analysis are valid. Second, the relatively
small numbers of detected and referred participants limited our
power to identify statistically significant predictors of referral con-
ditional on detection or uptake conditional on referral: only 51%
of our overall sample were detected, and only 18% were referred
for counseling, leaving sample sizes of 208 and 76, respectively.
Nonetheless, the descriptive statistics presented above provide a
basis for future inquiry into patient-level predictors of referral
and treatment uptake. Third, our data did not distinguish between
referrals to facility-based psychosocial counselors, physicians, psy-
chologists, or social workers, and the uptake outcome was
restricted to facility-based psychosocial counseling. This meant
we were unable to study rates and predictors of patient uptake
of specialized care, including prescription of anti-depressants by
a PHC physician or receipt of psychotherapy from a psychologist.
Further investigation is necessary to assess whether depressive
symptom severity and other forms of mental distress predict
referral to and uptake of appropriate treatment modalities
under a stepped care model (Katon et al., 1999). However,
given that the introduction or upskilling of a facility-based behav-
ioral counselor is the largest structural change required to adopt
the integrated care model, we argue that the rate of facility-based
counseling uptake is nevertheless a valuable indicator of the suc-
cess of integrated care implementation. Finally, this analysis did
not assess predictors of patients’ subsequent remission from
depression. Our focus was on movement through the integrated
care model, rather than the effectiveness of mental health treat-
ment. Notably, almost none of the participants in our sample
Fig. 2. Depression care cascade stratified by depressive symptom severity. Note: Error bars represent 95% confidence intervals.
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Table 1. Participant characteristics stratified by detection, referral, and uptake (n = 412)
Detection Referral (given detection) Uptake (given referral)
TotalFactor Not detected Detected pa Not referred Referred pa No uptake Any uptake p
N 204 208 132 76 58 18 412
Age, mean (S.D.) 44.6 (13.6) 44.0 (12.8) 0.69 44.5 (12.8) 43.2 (13.0) 0.39 43.8 (14.0) 41.5 (8.8) 0.13 44.3 (13.2)
Female 171 (83.8%) 166 (79.8%) 0.23 106 (80.3%) 60 (78.9%) 0.82 45 (77.6%) 15 (83.3%) 0.64 337 (81.8%)
Black 202 (99.0%) 208 (100%) 132 (100%) 76 (100%) 58 (100%) 18 (100%) 410 (99.5%)
Matriculated 41 (20.1%) 47 (22.6%) 0.38 31 (23.5%) 16 (21.1%) 0.67 13 (22.4%) 3 (16.7%) 0.60 88 (21.4%)
Employed 60 (29.4%) 52 (25.0%) 0.37 35 (26.5%) 17 (22.4%) 0.32 12 (20.7%) 5 (27.8%) 0.31 112 (27.2%)
Low income (2000 ZAR/month) 134 (65.7%) 151 (72.6%) 0.051 95 (72.0%) 56 (73.7%) 0.69 41 (70.7%) 15 (83.3%) 0.020 285 (69.2%)
Household food insecurity 84 (41.4%) 98 (47.1%) 0.24 59 (44.7%) 39 (51.3%) 0.39 27 (46.6%) 12 (66.7%) 0.036 182 (44.3%)
Healthcare use in previous 3 months
Other PHC visit 131 (64.2%) 127 (61.1%) 0.69 83 (62.9%) 44 (57.9%) 0.69 31 (53.4%) 13 (72.2%) 0.38 258 (62.6%)
Hospitalized 12 (5.9%) 9 (4.3%) 0.181 5 (3.8%) 4 (5.3%) 0.64 2 (3.4%) 2 (11.1%) 0.20 21 (5.1%)
Prior diagnoses
HIV 151 (74.8%) 167 (80.3%) 0.040 104 (78.8%) 63 (82.9%) 0.47 46 (79.3%) 17 (94.4%) 0.10 318 (77.6%)
Depression 6 (3.0%) 17 (8.2%) 0.020 8 (6.1%) 9 (11.8%) 0.36 9 (15.5%) 0 23 (5.6%)
Hypertension 58 (28.7%) 52 (25.0%) 0.38 39 (29.5%) 13 (17.1%) 0.026 10 (17.2%) 3 (16.7%) 0.94 110 (26.8%)
Diabetes 16 (7.9%) 19 (9.1%) 0.49 14 (10.6%) 5 (6.6%) 0.39 3 (5.2%) 2 (11.1%) 0.37 35 (8.5%)
Other chronic disease 57 (28.1%) 77 (37.2%) 0.019 57 (43.2%) 20 (26.7%) 0.005 16 (28.1%) 4 (22.2%) 0.66 134 (32.7%)
Number of prior chronic disease
diagnoses
0.039 0.049 0.46
0 2 (1.0%) 1 (0.5%) 1 (0.8%) 0 0 0 3 (0.7%)
1 131 (64.5%) 116 (55.8%) 68 (51.5%) 48 (63.2%) 35 (60.3%) 13 (72.2%) 247 (60.1%)
⩾2 70 (34.5%) 91 (43.8%) 63 (47.7%) 28 (36.8%) 23 (39.7%) 5 (27.8%) 161 (39.2%)
On depression medication 2 (1.0%) 1 (0.5%) 0.54 0 1 (1.3%) 1 (1.7%) 0 3 (0.7%)
PACIC, range 0–3, mean (S.D.) 0.45 (0.47) 0.44 (0.49) 0.97 0.41 (0.46) 0.50 (0.54) 0.46 0.47 (0.51) 0.60 (0.64) 0.09 0.44 (0.48)
PSS 0.005 0.72 0.33
Low stress 25 (12.4%) 4 (1.9%) 4 (3.1%) 0 0 0 29 (7.1%)
Moderate stress 145 (71.8%) 141 (68.1%) 87 (66.4%) 54 (71.1%) 43 (74.1%) 11 (61.1%) 286 (69.9%)
High stress 32 (15.8%) 62 (30.0%) 40 (30.5%) 22 (28.9%) 15 (25.9%) 7 (38.9%) 94 (23.0%)
Oslo social support 0.13 <0.001 0.13
Poor support 87 (43.1%) 102 (49.5%) 57 (43.5%) 45 (60.0%) 30 (52.6%) 15 (83.3%) 189 (46.3%)
Moderate support 74 (36.6%) 75 (36.4%) 52 (39.7%) 23 (30.7%) 21 (36.8%) 2 (11.1%) 149 (36.5%)
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Strong support 41 (20.3%) 29 (14.1%) 22 (16.8%) 7 (9.3%) 6 (10.5%) 1 (5.6%) 70 (17.2%)
WHODAS, range 0–1, mean (S.D.) 0.22 (0.18) 0.28 (0.19) 0.014 0.27 (0.19) 0.28 (0.20) 0.83 0.28 (0.21) 0.31 (0.15) 0.45 0.25 (0.19)
PHQ-9 0.013 0.99 0.52
Moderate depression 159 (77.9%) 119 (57.2%) 75 (56.8%) 44 (57.9%) 32 (55.2%) 12 (66.7%) 278 (67.5%)
Moderately severe depression 36 (17.6%) 59 (28.4%) 38 (28.8%) 21 (27.6%) 16 (27.6%) 5 (27.8%) 95 (23.1%)
Severe depression 9 (4.4%) 30 (14.4%) 19 (14.4%) 11 (14.5%) 10 (17.2%) 1 (5.6%) 39 (9.5%)
Any suicidal thoughts 58 (28.4%) 100 (48.1%) 0.03 70 (53.0%) 30 (39.5%) 0.053 21 (36.2%) 9 (50.0%) 0.17 158 (38.3%)
AUDIT 0.002 0.21 0.47
Low risk 170 (83.3%) 162 (77.9%) 99 (75.0%) 63 (82.9%) 49 (84.5%) 14 (77.8%) 332 (80.6%)
Risky or hazardous 24 (11.8%) 15 (7.2%) 10 (7.6%) 5 (6.6%) 4 (6.9%) 1 (5.6%) 39 (9.5%)
High-risk or harmful 5 (2.5%) 7 (3.4%) 6 (4.5%) 1 (1.3%) 1 (1.7%) 0 12 (2.9%)
High-risk and dependent 5 (2.5%) 24 (11.5%) 17 (12.9%) 7 (9.2%) 4 (6.9%) 3 (16.7%) 29 (7.0%)
S.D., standard deviation; ZAR, South African Rand; PHC, primary healthcare; PACIC, Patient Assessment of Care for Chronic Conditions scale; PSS, perceived stress scale; WHODAS, WHO Disability Assessment Schedule; PHQ-9, Patient Health
Questionnaire-9; AUDIT, Alcohol Use Disorders Identification Test.
ap values adjusted for clustering by health facility.
Bold indicates p < 0.05.
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Fig. 3. Predicted conditional probabilities of depression detection, treatment referral, and counseling uptake by depressive symptom severity. Note: Shaded areas
represent 95% confidence intervals.
Table 2. Generalized linear mixed-effects model estimates of predictors of detection, referral, and uptake
Detected (v. not detected) Referred (v. not referred) Any uptake (v. no uptake)
Predictors aOR 95% CI p aOR 95% CI p aOR 95% CI p
(Intercept) 0.01 0.00–0.08 <0.001 0.06 0.00–2.36 0.132 0 0.00–0.67 0.04
Age, years 1.01 0.99–1.03 0.396 1 0.97–1.03 0.99 1.05 0.96–1.16 0.268
Female 0.76 0.40–1.45 0.407 0.64 0.25–1.67 0.366 6.9 0.46–104.42 0.164
Matriculated 1.4 0.75–2.59 0.29 0.94 0.37–2.38 0.903 5.77 0.43–78.25 0.188
Employed 1.17 0.58–2.36 0.667 0.94 0.33–2.70 0.909 8.77 0.61–126.10 0.11
Income >2000 ZAR/month 0.97 0.50–1.89 0.926 0.63 0.23–1.69 0.356 4.3 0.33–56.75 0.268
Household food insecurity 1.19 0.72–1.98 0.498 1.72 0.80–3.70 0.167 4.33 0.43–43.79 0.214
Healthcare use in last 3 months
Other PHC use 1.15 0.65–2.03 0.64 0.87 0.38–2.01 0.744 2.8 0.48–16.29 0.252
Hospitalized 0.54 0.18–1.61 0.271 0.8 0.16–4.11 0.788 31.15 0.44–2204.28 0.114
Prior diagnoses
HIV 1.54 0.74–3.20 0.252 0.99 0.34–2.88 0.99 14.84 0.63–347.73 0.094
Depression 1.29 0.41–4.00 0.664 3.09 0.78–12.25 0.108 0 0.00–Inf 0.993
Other chronic disease 1.35 0.75–2.46 0.317 0.43 0.18–0.99 0.047 1.04 0.11–9.57 0.97
PACIC score 1.15 0.63–2.10 0.644 1.02 0.42–2.48 0.965 2.6 0.46–14.68 0.28
PSS score 1.11 1.06–1.17 <0.001 1.07 0.98–1.17 0.147 1.15 0.96–1.39 0.132
Oslo score 0.98 0.88–1.09 0.709 1.07 0.91–1.27 0.392 0.61 0.40–0.92 0.017
WHODAS score 0.6 0.13–2.77 0.514 1.65 0.17–15.74 0.663 11.54 0.02–5614.99 0.439
PHQ-9 score 1.12 1.04–1.20 0.004 1.04 0.94–1.16 0.402 0.78 0.59–1.03 0.076
Suicidal thoughts 1.78 1.02–3.11 0.041 0.57 0.25–1.33 0.195 1.22 0.14–10.92 0.858
AUDIT score 1.04 1.00–1.08 0.063 1.01 0.96–1.05 0.807 1.08 0.98–1.21 0.135
Random effects
σ2 3.29 3.29 3.29
τ00 1.11facility 2.31facility 2.33facility
ICC 0.25 0.41 0.41
Observations 402 203 75
aOR, adjusted odds ratio; CI, confidence interval; ZAR, South African Rand; PHQ-9, Patient Health Questionnaire-9; AUDIT, Alcohol Use Disorders Identification Test; PHC, primary healthcare;
PSS, perceived stress scale; WHODAS, WHO Disability Assessment Schedule; ICC, intraclass correlation.
Bold indicates p < 0.05.
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were currently taking anti-depressant medications; this is consist-
ent with other findings from South Africa (Fairall et al., 2016).
Nonetheless, our findings have significant implications for the
implementation of integrated, PHC-based mental health care in
South Africa and other lower-resource health systems implement-
ing similar models, including those in Ethiopia, Zimbabwe,
Uganda, and Haiti (Wagner et al., 2014; Wissow et al., 2014;
Chibanda et al., 2015; Duffy et al., 2017). Though rates of detec-
tion and referral closely matched those seen in higher-resource
settings, the mental health effects of drop-offs in the depression
treatment cascade are likely more egregious in this context. This
is because there is a paucity of alternative pathways to effective
mental health care in this and similar settings (Seedat et al.,
2009; Rathod et al., 2018), meaning patients with undetected or
untreated co-morbid depression will likely remain undetected
and untreated. Therefore, targeted implementation strategies are
warranted to increase detection and referral rates. For example,
brief educational interventions have been shown to improve
rates of appropriate nurse detection of, and care for, depressed
patients (Bruce et al., 2007). Validated screening tools for depres-
sion and other CMDs should also be considered for use at patient
intake (O’Connor et al., 2009); such tools are widely recom-
mended in systems with appropriate systems for subsequent diag-
nosis, treatment, and follow-up (US Preventive Services Task
Force, 2009), and are increasingly available and validated for
use in South Africa and other contexts (Bhana et al., 2019).
Strengthening patient demand for care – for example, by educat-
ing and mobilizing communities to improve mental health liter-
acy – will also be critical to improving rates of successful
service delivery (Shidhaye et al., 2017).
Conclusion
We assessed the patient-level predictors of movement through the
depression care cascade among patients with co-morbid chronic
disease and depressive symptoms in Amajuba District,
KwaZulu-Natal, South Africa. CNPs detected and referred chronic
patients at rates comparable to PHC settings around the world,
though substantial gaps persist. CNPs were more likely to detect
depressive symptoms in patients in more severe mental distress, sug-
gesting that the CNPs target and reserve care options for patients in
greater need. Severity of mental distress was not associated with
referral into treatment or counseling uptake, suggesting that higher-
level contextual factors may be inhibiting subsequent service deliv-
ery in this context. To ensure that integrated mental health care
reaches those who need it, strategies for implementation in low-
resource settings will need to incorporate targeted efforts to improve
rates of detection, referral, and treatment uptake.
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